Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
It is not approved for prescription, commercial, or personal use
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, with a partial sequence derived from body protection compound found in gastric juice
Most clients report immediate benefits such as increased energy, improved mood, and a sense of well-being Duration of Effects The effects of IV therapy can vary: Immediate Effects: Increased energy and improved hydration can be felt almost instantly and may last for several days
References Lancet Diabetes Endocrinology (2024) Efficacy and safety of coadministered onceweekly cagrilintide 2.4 mg with Semaglutide 2.4 mg in type 2 diabetes: phase 2 trial Lancet (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant cagrilintide with Semaglutide 2.4 mg: phase 1b trial Lancet (2021) Onceweekly cagrilintide for weight management: dosefinding phase 2 trial in overweight/obesity StatPearls (2025) Semaglutide: pharmacology, indications, and clinical use overview Cureus (2024) Semaglutide: risks and benefits review (PMC) WHO (2010) Best practices for injection and related procedures (WHO toolkit) SigmaAldrich (2016) Peptide Handling Guide: storage, reconstitution, and stability LibreTexts (2020) Intradermal and subcutaneous injections: clinical procedures CDC (2024) Vaccine administration: subcutaneous injection technique Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
US$ 25.03
US$ 24.23
US$ 22.70
US$ 21.35
US$ 25.22
US$ 23.74